التفاصيل البيبلوغرافية
| العنوان: |
The Cost Savings Potential of Biosimilar Drugs in the United States. |
| المؤلفون: |
Mulcahy, Andrew W.1 |
| المصدر: |
Medical Benefits. 12/15/2014, Vol. 31 Issue 23, p5-8. 3p. |
| مصطلحات موضوعية: |
*DRUG prices, *PHYSICIANS, BIOLOGICALS, DRUGS & economics, ANTINEOPLASTIC agents |
| مصطلحات جغرافية: |
UNITED States |
| الشركة/الكيان: |
RAND Corp. 024273161 |
| مستخلص: |
The article discusses a report by the U.S.-based research organization Rand Corp. as of November 2014 regarding cost saving potential of biosimilar drugs. Topics include 2013 sales of biosimilar drugs in the U.S.; estimated cost saving of biosimilars such as monoclonal antibody antineoplastics, anti-tumor necrosis factor (TNF) alpha products, and insulin; and effect of lower prices for the biologics on taxpayers and physicians. |
| قاعدة البيانات: |
Business Source Index |
Full Text Finder